These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6116855)

  • 1. Safety and immunogenicity of a new Haemophilus influenzae type b vaccine in infants under one year of age.
    King SD; Ramlal A; Wynter H; Moodie K; Castle D; Kuo JS; Barnes L; Williams CL
    Lancet; 1981 Oct; 2(8249):705-9. PubMed ID: 6116855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
    Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
    Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of a Haemophilus influenzae type b vaccine in combination with diphtheria-pertussis-tetanus vaccine in infants.
    Coulehan JL; Hallowell C; Michaels RH; Welty TK; Lui N; Kuo JS
    J Infect Dis; 1983 Sep; 148(3):530-4. PubMed ID: 6311913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
    Miller MA; Meschievitz CK; Ballanco GA; Daum RS
    Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
    JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of Haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age.
    Lepow ML; Samuelson JS; Gordon LK
    J Pediatr; 1985 Feb; 106(2):185-9. PubMed ID: 3871477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of infants to Haemophilus influenzae type b polysaccharide and diphtheria-tetanus-pertussis vaccines in combination.
    Lepow ML; Peter G; Glode MP; Daum RS; Calnen G; Knight KM; Mayer D; Kuo JS; Lui NS
    J Infect Dis; 1984 Jun; 149(6):950-5. PubMed ID: 6376656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine.
    Clemens JD; Ferreccio C; Levine MM; Horwitz I; Rao MR; Edwards KM; Fritzell B
    JAMA; 1992 Feb; 267(5):673-8. PubMed ID: 1731134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity in infants of a vaccine composed of Haemophilus influenzae type b capsular polysaccharide mixed with DPT or conjugated to diphtheria toxoid.
    Käyhty H; Eskola J; Peltola H; Stout MG; Samuelson JS; Gordon LK
    J Infect Dis; 1987 Jan; 155(1):100-6. PubMed ID: 3491858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
    Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
    Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants.
    Lee CY; Thipphawong J; Huang LM; Lee PI; Chiu HH; Lin W; Debois H; Harrison D; Xie F; Barreto L
    Pediatrics; 1999 Jan; 103(1):25-30. PubMed ID: 9917435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interchangeability of Haemophilus influenzae type b vaccines in the primary series: evaluation of a two-dose mixed regimen.
    Bewley KM; Schwab JG; Ballanco GA; Daum RS
    Pediatrics; 1996 Nov; 98(5):898-904. PubMed ID: 8909483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of Haemophilus influenzae type b conjugate vaccines in infant rhesus monkeys.
    Vella PP; Ellis RW
    Pediatr Res; 1991 Jan; 29(1):10-3. PubMed ID: 2000253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Haemophilus influenzae type b vaccines.
    Stieb DM; Frayha HH; Oxman AD; Shannon HS; Hutchison BG; Crombie FS
    CMAJ; 1990 Apr; 142(7):719-33. PubMed ID: 2107962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reimmunization of children immunized at 18 months of age with Haemophilus influenzae type b vaccine.
    Glode MP; Joffe LS; Brogden R; Kuo J
    J Pediatr; 1988 May; 112(5):703-8. PubMed ID: 3258908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid?
    Scheifele D; Barreto L; Meekison W; Guasparini R; Friesen B
    CMAJ; 1993 Oct; 149(8):1105-12. PubMed ID: 8221449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the combined administration of Haemophilus influenzae type B--diphtheria toxoid conjugate vaccine (PRP-D) and DTP.
    Gordon LK
    Dev Biol Stand; 1986; 65():113-21. PubMed ID: 3549393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses to a combination vaccine against Haemophilus influenzae type b, diphtheria, pertussis, and tetanus.
    Moxon ER; Anderson P; Smith DH; Blanca Adrianzen T; Graham GG; Baker RS
    Bull World Health Organ; 1975; 52(1):87-90. PubMed ID: 174825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the protective efficacy of Haemophilus influenzae type b vaccines in an animal model.
    Halsey NA; Johansen TL; Bowman LC; Glode MP
    Infect Immun; 1983 Mar; 39(3):1196-200. PubMed ID: 6601621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.